BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32845411)

  • 21. Recent advances in cutaneous lupus.
    Maz MP; Martens JWS; Hannoudi A; Reddy AL; Hile GA; Kahlenberg JM
    J Autoimmun; 2022 Oct; 132():102865. PubMed ID: 35858957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies.
    Little AJ; Vesely MD
    Yale J Biol Med; 2020 Mar; 93(1):81-95. PubMed ID: 32226339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies.
    Lee HJ; Sinha AA
    Autoimmunity; 2006 Sep; 39(6):433-44. PubMed ID: 17060022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging Therapies in Cutaneous Lupus Erythematosus.
    Sprow G; Dan J; Merola JF; Werth VP
    Front Med (Lausanne); 2022; 9():968323. PubMed ID: 35899214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous lupus erythematosus: a review.
    Patel P; Werth V
    Dermatol Clin; 2002 Jul; 20(3):373-85, v. PubMed ID: 12170873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of the evidence and cost of therapies for cutaneous lupus erythematosus.
    Rosen JD; Paul S; Maderal A
    Lupus; 2019 Jun; 28(7):799-805. PubMed ID: 31042129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical and Rare Forms of Cutaneous Lupus Erythematosus: The Importance of the Diagnosis for the Best Management of Patients.
    Herzum A; Gasparini G; Cozzani E; Burlando M; Parodi A
    Dermatology; 2022; 238(2):195-204. PubMed ID: 34082424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous Lupus Erythematosus: Progress and Challenges.
    Petty AJ; Floyd L; Henderson C; Nicholas MW
    Curr Allergy Asthma Rep; 2020 Apr; 20(5):12. PubMed ID: 32248318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.
    Stannard JN; Kahlenberg JM
    Curr Opin Rheumatol; 2016 Sep; 28(5):453-9. PubMed ID: 27270345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological therapies in the treatment of cutaneous lupus erythematosus.
    Presto JK; Hejazi EZ; Werth VP
    Lupus; 2017 Feb; 26(2):115-118. PubMed ID: 27687023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The classification and diagnosis of cutaneous lupus erythematosus.
    Kuhn A; Landmann A
    J Autoimmun; 2014; 48-49():14-9. PubMed ID: 24486120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous lupus erythematosus and cardiovascular disease: current knowledge and insights into pathogenesis.
    Guo LN; Nambudiri VE
    Clin Rheumatol; 2021 Feb; 40(2):491-499. PubMed ID: 32623651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on clinical trials for cutaneous lupus erythematosus.
    Xie L; Lopes Almeida Gomes L; Stone CJ; Faden DF; Werth VP
    J Dermatol; 2024 Mar; ():. PubMed ID: 38491743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment.
    Hejazi EZ; Werth VP
    Am J Clin Dermatol; 2016 Apr; 17(2):135-46. PubMed ID: 26872954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current Knowledge of the Molecular Pathogenesis of Cutaneous Lupus Erythematosus.
    Miyagawa F
    J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus.
    Wieczorek IT; Propert KJ; Okawa J; Werth VP
    JAMA Dermatol; 2014 Mar; 150(3):291-6. PubMed ID: 24477339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic and genetic considerations of cutaneous lupus erythematosus: a comprehensive review.
    Yu C; Chang C; Zhang J
    J Autoimmun; 2013 Mar; 41():34-45. PubMed ID: 23380467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicohistological and immunopathological features of patients with cutaneous lupus erythematosus at tertiary dermatology centre in Malaysia.
    Teh YC; Loo CH; Mohd Ali N; Lim AL; Tan WC
    Clin Exp Dermatol; 2022 Aug; 47(8):1490-1501. PubMed ID: 35315538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects.
    Moura Filho JP; Peixoto RL; Martins LG; Melo SD; Carvalho LL; Pereira AK; Freire EA
    An Bras Dermatol; 2014; 89(1):118-25. PubMed ID: 24626656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in cytokines in cutaneous and systemic lupus erythematosus.
    Mikita N; Ikeda T; Ishiguro M; Furukawa F
    J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.